Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients | Journal Scan

Study Questions:

Does advanced age impair efficacy of human mesenchymal stem cell (MSC) therapy for ischemic cardiomyopathy (ICM)?